- 英文名称
- Peracetyl Empagliflozin
- 分子式
- C31H35ClO11
- 分子量
- 619.06
- 中文别名
- (2R,3R,4R,5S,6S)-2-(乙酰氧甲基)-6-(4-氯-3-(4-((S)-四氢呋喃-3-基)氧基)苄基)苯基)四氢-2H-吡喃-3,4,5-三基三乙酸酯; (1S)-1,5-脱水-2,3,4,6-四-O-乙酰-1-C-[4-氯-3-[[4-[[(3S)-四氢呋喃-3]-基]氧基]苯基]甲基]苯基]-D-糖醇; (1S)-1,5-脱水-2,3,4,6-四-O-乙酰基-1-C-[4-氯-3-[[4-[[(3S)-四氢呋喃-3-基]氧基]苯基]甲基]苯基]-D-葡萄糖醇; (1S)-1,5-脱水-1-C-[4-氯-3-[[4-[[(3S)-四氢-3-呋喃基]氧基]苯基]甲基]苯基]-D-山梨糖醇四乙酸酯; 5-脱水-2,3,4,6-四-O-乙酰基-1-C-[4-氯-3-[[4-[[(3S)-四氢呋喃-3-基]氧基]苯基]甲基]苯基]-D-葡萄糖醇; 过乙酰基依帕列净; 依帕列净杂质25; 恩格列净杂质007; (2R,3R,4R,5S,6S)-2-(Acetoxymethyl)-6-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate; Acetoxy Empagliflozin; (1S)-2,3,4,6-Tetra-O-acetyl-1,5-anhydro-1-(4-chloro-3-{4-[(3S)-tetrahydro-3-furanyloxy]benzyl}phenyl)-D-glucitol; Empagliflozin Impurity 25; Empagliflozin impurity 13; [(2R,3R,4R,5S,6S)-3,4,5-Triacetyloxy-6-[4-chloro-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]oxan-2-yl]methyl acetate; Empagliflozin-10; D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-, 2,3,4,6-tetraacetate, (1S)-
- 用途
- 化学合成；作为合成恩格列净的中间体，恩格列净是钠-葡萄糖协同转运蛋白(SGLT2)抑制剂，用于治疗2型糖尿病，已在多国上市
